P

Inventor

KOLTUN ELENA S

US40 patents
⚠️ This page may combine multiple inventors who share the name “KOLTUN ELENA S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

REVOLUTION MEDICINES INC

23 patents
US10590090B2Mar 17, 2020

2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors

REVOLUTION MEDICINES INC28 citations92
US11952352B2Apr 9, 2024

Ras inhibitors

REVOLUTION MEDICINES INC6 citations85
US11608346B2Mar 21, 2023

Ras inhibitors

REVOLUTION MEDICINES INC9 citations85
US11566007B2Jan 31, 2023

Ras inhibitors

REVOLUTION MEDICINES INC10 citations85
US11739074B2Aug 29, 2023

Ras inhibitors

REVOLUTION MEDICINES INC9 citations84
US11690915B2Jul 4, 2023

Ras inhibitors

REVOLUTION MEDICINES INC9 citations82
US9957290B2May 1, 2018

Derivatives of amphotericin B

REVOLUTION MEDICINES INC8 citations82
US12465643B2Nov 11, 2025

Ras inhibitors

REVOLUTION MEDICINES INC1 citations74
US12280113B2Apr 22, 2025

Ras inhibitors

REVOLUTION MEDICINES INC2 citations74
US12202845B2Jan 21, 2025

Ras inhibitors

REVOLUTION MEDICINES INC3 citations74
US12252497B2Mar 18, 2025

Ras inhibitors

REVOLUTION MEDICINES INC3 citations73
US11168102B1Nov 9, 2021

Bicyclic heteroaryl compounds and uses thereof

REVOLUTION MEDICINES INC5 citations70
US12409225B2Sep 9, 2025

Ras inhibitors

REVOLUTION MEDICINES INC0 citations62
US12403196B2Sep 2, 2025

Ras inhibitors

REVOLUTION MEDICINES INC0 citations62
US12384750B2Aug 12, 2025

Ras inhibitors

REVOLUTION MEDICINES INC0 citations62
US11673896B2Jun 13, 2023

Pyridine compounds as allosteric SHP2 inhibitors

REVOLUTION MEDICINES INC1 citations61
US12565476B2Mar 3, 2026

2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors

REVOLUTION MEDICINES INC0 citations60
US11702411B2Jul 18, 2023

Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors

REVOLUTION MEDICINES INC0 citations60
US11661401B2May 30, 2023

2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors

REVOLUTION MEDICINES INC0 citations60
US12365688B2Jul 22, 2025

Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors

REVOLUTION MEDICINES INC0 citations59
US12258366B2Mar 25, 2025

Bicyclic heteroaryl compounds and uses thereof

REVOLUTION MEDICINES INC0 citations59
US11739093B2Aug 29, 2023

Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors

REVOLUTION MEDICINES INC1 citations59
US11673901B2Jun 13, 2023

Polycyclic compounds as allosteric SHP2 inhibitors

REVOLUTION MEDICINES INC0 citations47

EXELIXIS INC

5 patents

VALO HEALTH INC

4 patents

SFUNGA THERAPEUTICS INC

2 patents

INTEGRAL HEALTH INC

1 patent

TSUHAKO AMY L

1 patent

BRISTOL MYERS SQUIBB CO

1 patent

MANN GRACE

1 patent

RICE KENNETH D

1 patent

KOLTUN ELENA S

1 patent